Ledger.Open graph →
SEC Form D · filed October 31, 2024

XORTX Therapeutics Inc

Offering
$1.8M
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
Calgary, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Christopher J. Hirji · Calgary, Alberta, CanadaExec · DirectorAllen Davidoff · Calgary, Alberta, CanadaExec · DirectorPaul J. Van Damme · Calgary, Alberta, CanadaDirectorAbigail J. Jenkins · Calgary, Alberta, CanadaDirectorStephen Haworth · Calgary, Alberta, CanadaExecStacy Evans · Calgary, Alberta, CanadaExecJames Fairbairn · Calgary, Alberta, CanadaExecWilliam Farley · Calgary, Alberta, CanadaDirectorAnthony J. Giovinazzo · Calgary, Alberta, CanadaDirectorRaymond J. Pratt · Calgary, Alberta, CanadaDirectorPatrick J. Treanor · Calgary, Alberta, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗